Delivery Order SPE2DB20D2001-SPE2DB24FM44M

Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $7.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,107.10 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Cyclosporine 0.05% eye emulsion medication. The contract has a potential value of $1,954.08 and a performance period through February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,432.00 contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product. The delivery order has a potential value of $1,979.82 and a completion date of February 20, 2024. AmerisourceBergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor and does not have any major subcontractors listed. This...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,042.35 firm fixed price delivery order by the Defense Logistics Agency (DLA) for CYCLOSPORINE 0.05% EYE EMULS 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp as the sole prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $2,092.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Cyclosporine 0.05% eye emulsion. This award has a completion date of March 6, 2024 and is not set aside. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceutical...
This federal contract award, valued at $5,155.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of CYCLOSPORINE 0.05% EYE EMULS 60S. The contract is a Firm Fixed Price Delivery Order, with a completion date of July 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $12,801.03 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Cyclosporine 0.05% eye emulsion. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
The U.S. Defense Logistics Agency (DLA) awarded a $3,144.38 firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of 4564313232 - Cyclosporine 0.05% eye emulsion with an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FM44M
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for CYCLOSPORINE 0.05% EYE EMULS 60S. The delivery order has a potential value of $7,335.36 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals and medical supplies to U.S. government agencies, particularly the Department of Defense. The contract does not have a set-aside designation. In addition to this delivery order, Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.

Generated 5/10/24, 11:15 AM